Broker Upgrades and Downgrades & Key UK Corporate Snapshots 17 March 2016

UK Broker Upgrades / Downgrades

 

 

Code Company Broker Recomm. From Recomm. To Price From Price To
Upgrades
AAL Anglo American Plc Nomura Reduce Reduce 350 400
ACSO Accesso Technology Group Plc Peel Hunt Buy Buy 1200 1280
BBY Balfour Beatty Plc JP Morgan Cazenove Neutral Neutral 262 268
CNE Cairn Energy Plc Barclays Capital Equal weight Equal weight 190 220
CRH CRH Plc Deutsche Bank Hold Hold 1986 1993
DLG Direct Line Insurance Group Plc JP Morgan Cazenove Overweight Overweight 381 384
DPH Dechra Pharmaceuticals Plc RBC Capital Markets Sector Perform Outperform 1080 1320
GLEN Glencore Plc Nomura Reduce Reduce 80 85
JLIF John Laing Infrastructure Fund Ltd RBC Capital Markets Sector Performer Sector Performer 120 125
KAZ KAZ Minerals Plc Nomura Reduce Reduce 90 100
OSB OneSavings Bank Plc RBC Capital Markets Sector Perform Outperform 370
PRU Prudential Plc Barclays Capital Overweight Overweight 1754 1779
RTO Rentokil Initial Plc Credit Suisse Neutral Outperform
Downgrades
BLT BHP Billiton Plc Nomura Buy Neutral 950 850
CIU Cape Plc Investec Securities Buy Hold
CNE Cairn Energy Plc Liberum Capital Hold Sell
DGE Diageo Plc Deutsche Bank Buy Hold 1950 1800
FXPO Ferrexpo Plc Jefferies International Hold Underperform 20
GKN GKN Plc Berenberg Buy Buy 370 332
SMIN Smiths Group Plc Deutsche Bank Buy Buy 1240 1220
Initiate/Neutral/Unchanged
BAB Babcock International Group Plc JP Morgan Cazenove Overweight Overweight 1427 1427
BAG A.G.Barr Plc Barclays Capital Equal weight Equal weight 560 560
BDEV Barratt Developments Plc HSBC Buy 700
BDEV Barratt Developments Plc Deutsche Bank Buy Buy
BKG Berkeley Group Holdings Plc HSBC Buy 4290
BKG Berkeley Group Holdings Plc Deutsche Bank Buy Buy
BVIC Britvic Plc Citigroup Buy Buy
BVIC Britvic Plc Barclays Capital Overweight Overweight 825 825
BVS Bovis Homes Group Plc HSBC Buy 1450
BVS Bovis Homes Group Plc Deutsche Bank Buy Buy
BWY Bellway Plc HSBC Buy 3840
BWY Bellway Plc Deutsche Bank Hold Hold
CINE Cineworld Group Plc Citigroup Buy Buy 720 720
CIU Cape Plc JP Morgan Cazenove Neutral Neutral 240 240
CNA Centrica Plc Barclays Capital Equal weight Equal weight 230 230
CNA Centrica Plc Deutsche Bank Hold Hold 200 200
CRST Crest Nicholson Holdings Plc Deutsche Bank Hold Hold
DC. Dixons Carphone Plc Citigroup Buy Buy 560 560
DC. Dixons Carphone Plc Deutsche Bank Buy Buy 575 575
DRX Drax Group Plc Barclays Capital Overweight Overweight 320 320
DRX Drax Group Plc Deutsche Bank Hold Hold 200 200
ECEL Eurocell Plc Peel Hunt Buy Buy 240 240
GFRD Galliford Try Plc HSBC Buy 1800
HAS Hays Plc Liberum Capital Buy 155
HIK Hikma Pharmaceuticals Plc JP Morgan Cazenove Overweight Overweight
JDW JD Wetherspoon Plc Deutsche Bank Hold Hold 585 585
NG. National Grid Plc Barclays Capital Overweight Overweight 1065 1065
NG. National Grid Plc Deutsche Bank Hold Hold 900 900
PAYS Paysafe Group Plc Barclays Capital Overweight Overweight 560 560
PAYS Paysafe Group Plc Deutsche Bank Buy Buy 500 500
PLP Polypipe Group Plc Deutsche Bank Buy Buy
PNN Pennon Group Plc Deutsche Bank Buy Buy 900 900
PSN Persimmon Plc HSBC Buy 2640
PSN Persimmon Plc Deutsche Bank Hold Hold
RDW Redrow Plc HSBC Buy 630
RDW Redrow Plc Deutsche Bank Hold Hold
RIO Rio Tinto Plc Nomura Buy Buy
RWA Robert Walters Plc Liberum Capital Buy 470
SAGA Saga Plc JP Morgan Cazenove Neutral Neutral 207 207
SHI SIG Plc Deutsche Bank Hold Hold
SMIN Smiths Group Plc JP Morgan Cazenove Overweight Overweight 1250 1250
SN. Smith & Nephew Plc Nomura Neutral
SSE SSE Plc Barclays Capital Overweight Overweight 1660 1660
SSE SSE Plc Deutsche Bank Hold Hold 1450 1450
SVT Severn Trent Plc Deutsche Bank Buy Buy 2300 2300
TLW Tullow Oil Plc Nomura Reduce Reduce 140 140
TLW Tullow Oil Plc Barclays Capital Overweight Overweight 280 280
TLW Tullow Oil Plc Deutsche Bank Hold Hold 230 230
TPK Travis Perkins Plc Deutsche Bank Buy Buy
TW. Taylor Wimpey Plc HSBC Buy 210
TW. Taylor Wimpey Plc Deutsche Bank Buy Buy
UU. United Utilities Group Plc Deutsche Bank Buy Buy 1000 1000

 

US Broker Upgrades / Downgrades

 

 

Code Company Broker Recomm. From Recomm. To Price From Price To
Upgrades
CRNCY Cairn Energy Credit Suisse Underperform  Neutral
GLOP GasLog Partners JP Morgan Underweight  Neutral
K Kellogg Goldman Sachs Sell  Neutral
LM Legg Mason Credit Suisse Neutral  Outperform
MJN Mead Johnson Nutrition Credit Suisse Neutral  Outperform
SHW Sherwin-Williams Longbow Neutral  Buy
Downgrades
AKAO Achaogen Needham Buy  Hold
NGLOY Anglo American Citigroup Neutral  Sell
ANFGY Antofagasta Citigroup Buy  Neutral
BCS Barclays Keefe, Bruyette & Woods Outperform  Market Perform
CMG Chipotle Mexican Grill Maxim Group Hold  Sell $450 $350
CPSS Consumer Portfolio Services JMP Securities Market Outperform  Market Perform
CACC Credit Acceptance Corp. JMP Securities Market Perform  Market Underperform
DSW DSW Johnson Rice Buy  Accumulate
EL Estee Lauder Goldman Sachs Buy  Neutral
EVRI Everi Holdings Craig Hallum Buy  Hold
FDS FactSet Research Systems Stifel Buy  Hold
FOSL Fossil Group Macquarie Neutral  Underperform
GCAP Gain Capital Holdings Raymond James Outperform  Market Perform
GPS Gap Morgan Stanley Equal weight  Underweight
GLOG GasLog JP Morgan Neutral  Underweight
HCP HCP UBS Buy  Neutral $31 $31
LNKD LinkedIn Morgan Stanley Overweight Equal weight
LNMIY Lonmin Citigroup Neutral  Sell
MOS Mosaic Morgan Stanley Overweight Equal weight
MTNOY MTN Group Goldman Sachs Neutral  Sell
OREX Orexigen Therapeutics JMP Securities Market Outperform  Market Perform
OREX Orexigen Therapeutics Piper Jaffray Overweight  Neutral
PHM PulteGroup BofA Merrill Lynch Neutral  Underperform
REGN Regeneron Pharmaceuticals Chardan Capital Markets Neutral  Sell $375 $325
SC Santander Consumer USA Holdings JMP Securities Market Outperform  Market Perform
SUNE SunEdison Avondale Market Outperform  Market Perform
TCKGY Thomas Cook Group Citigroup Neutral  Sell
VRX Valeant Pharmaceuticals International CIBC Sector Perform  Sector Underperform
VRX Valeant Pharmaceuticals International Nomura Buy  Neutral $175 $60
VEC Vectrus Sidoti Buy  Neutral
Initiated
ABC AmerisourceBergen Credit Suisse Outperform
BBBY Bed Bath & Beyond Guggenheim Neutral
BIG Big Lots Credit Suisse Underperform
CSIQ Canadian Solar Northland Capital Outperform
CAH Cardinal Health Credit Suisse Outperform
XRAY DENTSPLY SIRONA Credit Suisse Outperform
DPLO Diplomat Pharmacy Credit Suisse Neutral
EVOK Evoke Pharma Northland Capital Outperform
ESRX Express Scripts Holding Credit Suisse Outperform
HSIC Henry Schein Credit Suisse Neutral
LH Laboratory Corp of America Holdings Credit Suisse Outperform
LIMAF Linamar Gabelli & Co Buy $101
MCK McKesson Credit Suisse Neutral
OMI Owens & Minor Credit Suisse Underperform
PDCO Patterson Companies Credit Suisse Outperform
PMC PharMerica Credit Suisse Outperform
PIR Pier 1 Imports Guggenheim Neutral
QEP QEP Resources KLR Group Buy
DGX Quest Diagnostics Credit Suisse Neutral
RVLT Revolution Lighting Technologies Rodman & Renshaw Buy $20
SCI Service Corp International Credit Suisse Neutral

 

Key UK Corporate Snapshots Today

Arbuthnot Banking Group (ARBB.L)  Announced, in its audited final results for the year to 31 December 2015, that operating imcome stood at £126.7 million, compared to £92.05 million in the same period last year. Profit for the year was £27.82 million, compared to £17.31 million. Basic earnings per share stood at 86.3p, compared to 58.6p. Diluted earnings per share was 83.3p, compared to 52.8p. The disposal of Everyday Loans is proceeding as expected. Once it has completed, the Board is proposing a special dividend for 2016 of 25p, of which details will be announced later.

Brooks Macdonald Group Plc (BRK.L)  Announced, in its report for the six months ended 31 December 2015, that revenue stood at £38.70 million, compared to £37.50 million in the same period last year. Operating profit stood at £5.86 million, compared to £4.94 million. Profit after tax was £4.37 million, compared to £3.56 million. Diluted earnings per share stood at 32.28p, compared to 26.51p. The board has declared an interim dividend of 12p (2014: 10p).

C4X Discovery Holdings Plc (C4XD.L)  Announced, in its interim results for the six months ended 31 January 2016, that its reported revenue stood at £0.1 million, compared to £0.1 million in the preceding year. Operating loss stood at £3.4 million, compared to loss of £1.2 million. Net loss after tax was £2.7 million compared to loss of £1.0 million. The company’s diluted loss per share was 8.76p, compared to loss of 3.86p.

Cello Group Plc (CLL.L)  Announced, in its final results for the year ended 31 December 2015, that revenues fell to £157.3 million from £169.9 million recorded in the previous year. Profit after tax widened to £3.0 million from £2.3 million. The Board proposed a final dividend of 2.02p per share (2014: 1.80p), giving a total dividend for the year of 2.86p per share (2014: 2.60p) representing an increase of 10.0%.

Clarkson Plc (CKN.L)  Announced that it has received notification that on 17 March 2016 a number of former shareholders of RS Platou ASA sold 2,034,416 ordinary shares in the capital of the Company in London at a price of 1840p per ordinary share pursuant to the secondary placing announced on 16 March 2016. Peter M. Anker, a PDMR of the Company, has sold 169,000 Placing Shares as part of the Placing. Post transaction, Peter M. Anker holds 357,477 existing ordinary shares and 2,667 conditional awards in the capital of the company, equivalent to 1.2% of issued ordinary share capital.

GlaxoSmithKline Plc (GSK.L)  Announced that Sir Andrew Witty, CEO, has indicated to the Board his intention to retire from the company in early 2017. The Board has agreed that he will retire on 31st March 2017. The Board will now conduct a formal search for a successor and will consider internal and external candidates for the role. Separately, the company announced that Sir Deryck Maughan, Dr Stephanie Burns, Dr Daniel Podolsky and Hans Wijers would not stand for re-election to the Board at GSK’s Annual General Meeting on 5 May 2016 (the “AGM”).

Hurricane Energy Plc (HUR.L)  Announced that Alistair Stobie has been appointed as a Chief Financial Officer and Director of the company with immediate effect.

Imperial Innovations Group Plc (IVO.L)  Announced that TopiVert Pharma Ltd stated that the phase I study results for TOP1288, its lead compound for the treatment of ulcerative colitis (UC), showed positive results. The company has 30.6% interest in TopiVert Pharma Ltd as on 31 July 2015. TopiVert now plans to start a Phase II proof of concept study with a rectal formulation of TOP1288 in UC patients in mid-2016, for which the company is anticipating the results by mid-2017. TopiVert is also planning to start a Phase I study of an oral formulation of TOP1288 in the second half of this year.

Keras Resources Plc (KRS.L)  Announced that it has completed its first blast at the Anomaly 22 project, located in the Grants Patch Gold Tribute lease area in the prospective Western Australian goldfields. The company expects the mining to commence by 21 March 2016 which will be a part of its initial bulk sample of up to 10,000 tonnes to confirm grade continuity, mining practices and ore delivery mechanisms to the Paddington Mill.

Kier Group Plc (KIE.L)  Announced, in its unaudited interim results for the six months ended 31 December 2015, that Group revenue stood at £2032.4 million, compared to £1561.7 million in the preceding period. Profit after tax was £15.1 million compared to £22.3 million. The company’s diluted earnings per share was 15.4p, compared to 31.6p.

LondonMetric Property Plc (LMP.L)  Announced that it has acquired three distribution warehouses for £21.8 million, totalling 212,600 sq ft and reflecting a NIY of 6.6%, which contractually rises to 6.9% within two years. The warehouses are located in Castle Donington, Royston and Hemel Hempstead and are let to toy retailer Hamleys, Howdens and Goodrich respectively for a total rent of £1.5 million pa and an average WAULT of 12.4 years.

Marshall Motor Holdings Plc (MMH.L)  Announced, in its annual results for the twelve months ended 31 December 2015, that revenue stood at £1,232.76 million, compared to £1,085.89 million in the same period last year. Operating profit stood at £18.25 million, compared to £15.24 million. Profit after tax was £11.71 million, compared to £9.94 million. Diluted earnings per share from continuing operations stood at 19.2p, compared to 282.6p. The board is pleased to recommend a final dividend of 2.40p per share, which, with the pro-rata interim dividend of 0.58p per share gives a total dividend for the year of 2.98p per share.

ONESAVINGS BANK Plc (OSB.L)  Announced, in its final results for the year ended 31 December 2015, that total income rose to £162.5 million from £118.9 million recorded in the previous year. Profit after tax widened to £84.1 million from £51.5 million. The Board recommended a final dividend of 6.7p per share in line with our stated dividend policy. This gives a total dividend per share for the full year of 8.7p.

OptiBiotix Health Plc (OPTI.L)  Announced that it has entered into a joint venture agreement with The University of Manchester and has acquired the exclusive rights of the intellectual property developed by the University in skin health. The joint venture will be called SkinBiotix Limited in which the company holds the majority stake. Under the terms of the agreement, the company has invested £260,000 into the JV and will own 52% of SkinBiotix Limited, with the remaining 48% owned by the University of Manchester and key researchers.

Port Erin Biopharma Investments Limited (PEBI.L)  Announced, in its unaudited interim results for the six months ended 31 December 2015, that its operating loss stood at £0.18 million, compared to £0.14 million. Loss net of tax was £0.18 million compared to £0.14 million. The company’s basic and diluted loss per share was 0.79p, compared to 0.42p.

ProPhotonix Limited (PPIX.L)  Announced an extension to its UV LED Curing systems, the COBRA Cure FX2, which provides more intense UV curing critical to the printing industry, coatings industry, 3D printing, and other applications.

Rio Tinto Plc (RIO.L)  Announced that the company’s chief executive Sam Walsh will retire from the business on 01 July 2016 and will be succeeded by Copper & Coal chief executive Jean-Sébastien Jacques. To ensure a smooth transition, Jean-Sébastien, will join the board and become deputy chief executive with immediate effect.

Safestyle UK Plc (SFE.L)  Announced, in its final results for the year ended 31 December 2015, that its reported revenue stood at £148.9 million, compared to £136.0 million in the preceding year. Profit after tax was £13.9 million compared to £12.8 million. The company’s diluted earnings per share was 17.3p, compared to 15.9p.

Secure Trust Bank Plc (STB.L)  Announced, in its final results for the year ended 31 December 2015, that its net interest income stood at £78.9 million, compared to £49.2 million in the preceding year. Profit after tax was £19.3 million compared to £13.9 million. The company’s diluted earnings per share was 154.8p, compared to 119.9p.

Serica Energy Plc (SQZ.L)  Announced, in its Erskine Operations Update, that strong production performance through January and February, averaging 3,228 boe per day net to the company, March Erskine production has been impacted by a pipeline blockage. The overall impact is to reduce Q1 average production to approximately 2,100 boe per day net to the company, compared to previous guidance of 2,500 to 3,000 boe per day. Reservoir performance since acquisition last June continues to provide significant encouragement with little observed pressure decline and peak production rates still well over 4,000 boe per day to the company.

Snacktime Plc (SNAK.L)  Announced that the Annual Report for the period ended 27 March 2015 has been despatched to shareholders as is available at www.snacktime.com. On page 6 of the Annual Report reference is made to the expectation that trading in the company’s shares on AIM will resume on 16 March 2016. At this point the company is continuing to discuss timing for restoration of trading in its shares with its advisers. A further announcement will be made in due course.

Sopheon Plc (SPE.L)  Announced, in its final results for the year ended 31 December 2015, that revenue stood at $20.89 million, compared to $18.30 million in the same period last year. Operating profit stood at $1.55 million, compared to a loss of $1.10 million. Profit after tax was $1.13 million, compared to a loss of $1.52 million. Diluted earnings per share stood at 13.90c, compared to a loss of 20.87c.

Spire Healthcare Group Plc (SPI.L)  Announced, in its results for the year ended 31 December 2015, that its reported revenue stood at £884.8 million, compared to £856.0 million in the preceding year. Profit after tax was £60.0 million compared to loss net of tax of £6.0 million. The company’s diluted earnings per share was 14.9p, compared to loss per share of 1.9p.

Ted Baker Plc (TED.L)  Announced, in its annual results for the 52 weeks ended 30 January 2016, that revenue stood at £456.2 million, compared to £387.6 million in the same period last year. Operating profit stood at £59.37 million, compared to £49.76 million. Profit after tax was £44.24 million, compared to £35.85 million. Basic earnings per share stood at 100.6p, compared to 82.0p. Diluted earnings per share was 99.3p, compared to 81.0p. The proposed final dividend of 34.6p per share will make a total for the period of 47.8p per share (2015: 40.3p per share), an increase of 18.6% on the previous year.

Tern Plc (TERN.L)  Announced that at the Annual General Meeting to be held today, Chairman, Angus Forrest, will state that since the publication of the annual results for the year ended 31 December 2015, it has raised £1.1 million in a placing despite the uncertainty surrounding capital markets for investment in accordance with the company’s investing policy. He will also mention that the company and its portfolio have continued to make progress towards achieving the agreed objectives, primarily increasing commercialisation and monetisation of the assets.

Ubisense Group Plc (UBI.L)  Announced new contracts in North America for its Geospatial division, valued at a combined $2.9 million, are with Tier 1 broadband communications and entertainment providers and one of the largest power companies in the United States. The company will provide managed services for its flagship myWorld product and other systems used to manage and visualise the network assets of both customers. Moreover, these wins will provide a solid contribution to the Group’s planned revenues in the current year with the potential for additional revenue as the customers’ use of the products expands. The company will announce its annual results for the year ended 31 December 2015 on Thursday 7 April 2016.

ULS Technology Plc (ULS.L)  Announced that it has launched its Will Writing comparison and introduction service through two major partners. The new exclusive agreements, one with a leading property group and the other with a leading mortgage network, will allow more than 400 mortgage advisers to compare will writing and other estate planning services through ULS for both existing and new customers.

Vernalis Plc (VER.L)  Announced, in its unaudited interim results for the six months ended 31 December 2015, that its reported revenue stood at £6.12 million, compared to £5.70 million in the preceding period. Loss net of tax was £7.62 million compared to profit after tax of £1.68 million. The company’s basic and diluted loss per share was 1.7p, compared to earnings per share of 0.4p.

Click to view all articles for the EPIC: , ,
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Guardian Stockbrokers

    More articles like this